A Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer

NCT06316531 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

274

Enrollment

INDUSTRY

Sponsor class

Conditions

HER2-positive Breast Cancer

Interventions

DRUG: BL-M07D1
DRUG: T-DM1

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

[object Object]